One day, we will learn the extent of the malicious war that was waged by politicians and Big Pharma against COVID treatments. But if the newest study on proxalutamide in COVID patients reflects reality, you can add one more drug to the list of treatments that could have saved countless lives but which were purposefully stifled to please the gods of lockdowns, panic, and experimental injections. Last week, Kintor Pharmaceuticals announced the results of a randomized controlled trial of the use of anti-androgen proxalutamide, a prostate cancer drug, in mild to moderate COVID patients. It found that among the 721...